| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | Ig_sub | 2.85e-04 | 421 | 15 | 4 | IPR003599 | |
| Domain | IG | 2.85e-04 | 421 | 15 | 4 | SM00409 | |
| Domain | I-set | 4.31e-04 | 190 | 15 | 3 | PF07679 | |
| Domain | Ig_I-set | 4.31e-04 | 190 | 15 | 3 | IPR013098 | |
| Domain | IG_LIKE | 5.11e-04 | 491 | 15 | 4 | PS50835 | |
| Domain | Ig-like_dom | 5.60e-04 | 503 | 15 | 4 | IPR007110 | |
| Domain | Ig_sub2 | 8.00e-04 | 235 | 15 | 3 | IPR003598 | |
| Domain | IGc2 | 8.00e-04 | 235 | 15 | 3 | SM00408 | |
| Domain | - | 1.57e-03 | 663 | 15 | 4 | 2.60.40.10 | |
| Domain | Ig-like_fold | 1.98e-03 | 706 | 15 | 4 | IPR013783 | |
| Domain | Cys-rich_flank_reg_C | 2.31e-03 | 90 | 15 | 2 | IPR000483 | |
| Domain | LRRCT | 2.31e-03 | 90 | 15 | 2 | SM00082 | |
| Domain | fn3 | 7.29e-03 | 162 | 15 | 2 | PF00041 | |
| Domain | LRR_8 | 8.09e-03 | 171 | 15 | 2 | PF13855 | |
| Domain | Leu-rich_rpt_typical-subtyp | 8.65e-03 | 177 | 15 | 2 | IPR003591 | |
| Domain | LRR_TYP | 8.65e-03 | 177 | 15 | 2 | SM00369 | |
| Domain | FN3 | 9.41e-03 | 185 | 15 | 2 | SM00060 | |
| Domain | Immunoglobulin | 9.91e-03 | 190 | 15 | 2 | IPR013151 | |
| Domain | ig | 9.91e-03 | 190 | 15 | 2 | PF00047 | |
| Domain | FN3 | 1.08e-02 | 199 | 15 | 2 | PS50853 | |
| Domain | LRR | 1.10e-02 | 201 | 15 | 2 | PS51450 | |
| Domain | FN3_dom | 1.19e-02 | 209 | 15 | 2 | IPR003961 | |
| Domain | EGF_3 | 1.49e-02 | 235 | 15 | 2 | PS50026 | |
| Domain | EGF_1 | 1.73e-02 | 255 | 15 | 2 | PS00022 | |
| Domain | EGF_2 | 1.86e-02 | 265 | 15 | 2 | PS01186 | |
| Domain | Leu-rich_rpt | 1.94e-02 | 271 | 15 | 2 | IPR001611 | |
| Domain | - | 2.67e-02 | 321 | 15 | 2 | 3.80.10.10 | |
| Domain | L_dom-like | 2.78e-02 | 328 | 15 | 2 | IPR032675 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | 5.02e-05 | 1489 | 17 | 6 | 28611215 | |
| Pubmed | 6.43e-05 | 162 | 17 | 3 | 25826454 | ||
| Pubmed | 1.25e-04 | 34 | 17 | 2 | 18848646 | ||
| Interaction | CLEC4A interactions | 6.92e-05 | 103 | 16 | 3 | int:CLEC4A | |
| Cytoband | 19q13.2 | 1.67e-03 | 164 | 17 | 2 | 19q13.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q34 | 6.33e-03 | 325 | 17 | 2 | chr9q34 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | 9.04e-03 | 1192 | 17 | 3 | chr19q13 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 7.94e-05 | 161 | 10 | 3 | 593 | |
| GeneFamily | Fibronectin type III domain containing | 3.34e-03 | 160 | 10 | 2 | 555 | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-CD1c+_DCs|normal_Pleural_Fluid / Location, Cell class and cell subclass | 3.59e-05 | 172 | 17 | 3 | 200b2e63313b110b8ca59ee5b72c02cc8ed907cd | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.25e-05 | 182 | 17 | 3 | 3d7a8d2ee2137b098248597058974ef5ae09c19e | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.75e-05 | 189 | 17 | 3 | bfb1c183a8a2752a2368b74150e66181c6a9da48 | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.75e-05 | 189 | 17 | 3 | 14833feea8f80744a06ece73f813eaeff8c4dd61 | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.75e-05 | 189 | 17 | 3 | 1db5dd1ef2a65251af2d5696622d1dd9c4ae2b55 | |
| ToppCell | LPS_only-Unknown|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.59e-04 | 115 | 17 | 2 | 7a733f6987b40ec497a03734b79ed5355ad3a2fc | |
| ToppCell | LPS_only-Unknown-Endothelial-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.59e-04 | 115 | 17 | 2 | c67145d3cd9243994a141749b426ff2a6dcc8d93 | |
| ToppCell | LPS_only-Unknown-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.59e-04 | 115 | 17 | 2 | ad5298c2ad8bf94fa13c2e50b0799e929473ef59 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-03 | 137 | 17 | 2 | 4dcb15de821439011df1bb0bbd7682d674bd725d | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-03 | 137 | 17 | 2 | c05ceeb7b483324604cb3f647d2da2b3786071b1 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_dendritic-plasmacytoid_dendritic_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.30e-03 | 142 | 17 | 2 | 7fa6b0f493634d25d68b4365b8c82cd43f5d31db | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Reln_Itm2a|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.34e-03 | 144 | 17 | 2 | 0bbe670454846cf9bc7464ae4e91488415c4111d | |
| ToppCell | facs-Lung-3m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l21|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.43e-03 | 149 | 17 | 2 | efa30fcd9370f98eb7445f295eb4d0305ff455c3 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c08-GZMK-FOS_h|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.49e-03 | 152 | 17 | 2 | 6aad62b5b5ad2f78c6600f37960338d40628a439 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM2|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.51e-03 | 153 | 17 | 2 | decc4f3098a9374a6b65c015a9d36380986290bf | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.51e-03 | 153 | 17 | 2 | 5fbb90b8477f9fdabf3be19efd3068fbf70abee6 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM2-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.51e-03 | 153 | 17 | 2 | 36a28805c0545c2f410c74a6ca0a70d840e75715 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM2-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.51e-03 | 153 | 17 | 2 | 2c46183481e6d5a7fa190a743062509465f88e56 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-03 | 154 | 17 | 2 | 37765512dfae557b9f6eb30a29463b93682a4404 | |
| ToppCell | Adult-Immune-enucleated_erythrocyte|Adult / Lineage, Cell type, age group and donor | 1.55e-03 | 155 | 17 | 2 | e2d07ee4348d2c1d3552a8d0337ea42777c31f9c | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-03 | 156 | 17 | 2 | d5207dbfbcfb885557ea1378dfe6a56d7102e94a | |
| ToppCell | IIH-CD8-memory_CD4|IIH / Condition, Cell_class and T cell subcluster | 1.57e-03 | 156 | 17 | 2 | e312fc4317d966fb2b570d1a4a3aa865f781ea93 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-03 | 156 | 17 | 2 | 363f1b661048d25895e2b8681c82894c957b29c0 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.59e-03 | 157 | 17 | 2 | f147e24f2ece82e1c54750868954d09b3c461804 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.61e-03 | 158 | 17 | 2 | e5636c0b608d68bd426a2b446ac508e4512e86a4 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-5|TCGA-Stomach / Sample_Type by Project: Shred V9 | 1.63e-03 | 159 | 17 | 2 | c40fe552da3abdb1df87e9e1647468dc038bec0a | |
| ToppCell | Basal_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 1.65e-03 | 160 | 17 | 2 | b223cc47e68a29df4758c5ccf8f6dbffe2a6fa1d | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_8|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.67e-03 | 161 | 17 | 2 | 7e0b8119cea208c0b4a0dffdf94ff6137d0b4c90 | |
| ToppCell | Influenza_Severe-Neutrophil|Influenza_Severe / Disease group and Cell class | 1.67e-03 | 161 | 17 | 2 | 98c95b1b85d5427415af2ca8fb14849e97f6e8b5 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c09-SLC4A10|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.69e-03 | 162 | 17 | 2 | 3b89c3758835b7b9f9d4fb0bc8ed06da382fe48b | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_8|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.69e-03 | 162 | 17 | 2 | 2fd6e8f48b48d509a7533cec2f79089513c34a2f | |
| ToppCell | Mild_COVID-19-Myeloid-MoAM2|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.69e-03 | 162 | 17 | 2 | e5fc80ab19d513af6a7e677a5e67bfebca2e963b | |
| ToppCell | Control-Epithelial-Ionocyte|World / Disease state, Lineage and Cell class | 1.69e-03 | 162 | 17 | 2 | e3b9b46ce2faff7d099502df14bbf51e9f183f8c | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_dendritic|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.69e-03 | 162 | 17 | 2 | 233011408f022647932c81ebab78f9813e3c6833 | |
| ToppCell | AT1-AT2_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 1.69e-03 | 162 | 17 | 2 | 57d627259d27f39885bf416d74bcb6656db6e27b | |
| ToppCell | 10x5'-Liver-Lymphocytic_Invariant-Inducer-like-ILC3|Liver / Manually curated celltypes from each tissue | 1.71e-03 | 163 | 17 | 2 | 7f61483eeb1fde21843c6391468e13cb0cc2a89f | |
| ToppCell | IIF-Other-HSPC|IIF / Disease, Lineage and Cell Type | 1.71e-03 | 163 | 17 | 2 | 1e0d38fbed38ac48478868a1480172a1a3f7c1b7 | |
| ToppCell | BAL-Severe-cDC_8|Severe / Compartment, Disease Groups and Clusters | 1.73e-03 | 164 | 17 | 2 | e8cbe7e01eca32886eb44e02d5333056b6bebc50 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Reln_Tac1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.75e-03 | 165 | 17 | 2 | d8df50f5a3b646e8ea13739fdc65ce6f39b4d4d2 | |
| ToppCell | COVID-19_Mild-PLT_0|COVID-19_Mild / Disease Group and Platelet Clusters | 1.75e-03 | 165 | 17 | 2 | 083a14d3b0162cee4e79f7398b8fb739582b39ff | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Reln_Tac1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.77e-03 | 166 | 17 | 2 | 59d47c1fca7a8c70f6998f3367a9dbcb9b67966f | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Tpbg|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.77e-03 | 166 | 17 | 2 | b4241f8d2a0aa910dbb0d0d5d3631a9b73453fe9 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.80e-03 | 167 | 17 | 2 | 83969c36ac44b96afc9aa09400a99fa2b487f7ff | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.82e-03 | 168 | 17 | 2 | 2572a3dd4f3f619bd26a3cd6e60de43821d8bb64 | |
| ToppCell | droplet-Kidney-nan-21m-Lymphocytic-plasma_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-03 | 168 | 17 | 2 | bc7d5f0e5d222922eaf1c8e8c87aab189209d6b6 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-6_VIP_PENK|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.84e-03 | 169 | 17 | 2 | eb3b8e473192c4b8688f2f8da400116dd6fe193d | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Ptprt_Pkp2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.86e-03 | 170 | 17 | 2 | 14aa86a4f526ed6986afcb28c49225522055550c | |
| ToppCell | 10x5'-Liver-Myeloid_Mac-Intermediate_macrophages|Liver / Manually curated celltypes from each tissue | 1.88e-03 | 171 | 17 | 2 | 25e0333743affdb662223fb5220b8a61fa02ad9f | |
| ToppCell | (0)_Normal/No_Treatment-(4)_COL2.3+_osteoblasts|(0)_Normal/No_Treatment / Stress and Cell class | 1.92e-03 | 173 | 17 | 2 | c2a0f674681836b5a868c13f67caa7d555ef6519 | |
| ToppCell | severe_influenza-Neutrophil|severe_influenza / disease group, cell group and cell class (v2) | 1.92e-03 | 173 | 17 | 2 | 615e266419b9f06e964eff73cb466f05451ba0dd | |
| ToppCell | 10x5'-blood-Lymphocytic_Invariant-Inducer-like|blood / Manually curated celltypes from each tissue | 1.95e-03 | 174 | 17 | 2 | 51be6f29308c01593978cbee92114151a5916c9c | |
| ToppCell | severe_influenza-Neutrophil|World / disease group, cell group and cell class (v2) | 1.95e-03 | 174 | 17 | 2 | f9f07436b7d3f190800cd85d229f007032f391e1 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.97e-03 | 175 | 17 | 2 | 1d8da48236549c01381f777ce5b2937f9f86acc2 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L1-3_PVALB_WFDC2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.97e-03 | 175 | 17 | 2 | 955f10982a487e12cdc3a9f80b3be06bf6c59de7 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.97e-03 | 175 | 17 | 2 | 553e68e8b439a2293efb969e1e2aa017ceb80daf | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.97e-03 | 175 | 17 | 2 | 16d4e97271df1db9a0d167fc82a90d84d20dd1f2 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-Other_T|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.97e-03 | 175 | 17 | 2 | 289d2aa7164bc02b1876b99f2fb67baa8e030c4e | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.01e-03 | 177 | 17 | 2 | 85e270b4a0b0da77ffe5987a099e827c02a4adf3 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.01e-03 | 177 | 17 | 2 | b872ee91e01265b101b81bd304cf6b95d5419e68 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.04e-03 | 178 | 17 | 2 | edc76b8f15056ec1c9a1c61a048b6331a92592d6 | |
| ToppCell | severe-Others-CD34+_GATA2+_cells|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.06e-03 | 179 | 17 | 2 | dd789a1b7327d6f9ed5272f3eb54bd43f7ae8d78 | |
| ToppCell | droplet-Lung-3m-Epithelial-alveolar_epithelial-type_I_pneumocyte-type_1_alveolar_epithelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.06e-03 | 179 | 17 | 2 | ca70a5518c5a5392e088c103e0cb44aa084f5332 | |
| ToppCell | droplet-Lung-3m-Epithelial-alveolar_epithelial-type_I_pneumocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.06e-03 | 179 | 17 | 2 | c451b074b04eb5d6c575c6abaedda579c6744bbf | |
| ToppCell | mild_COVID-19_(asymptomatic)-cDC|World / disease group, cell group and cell class (v2) | 2.08e-03 | 180 | 17 | 2 | 68d1c867734fb2977b01ac686b20bf602f9a6b72 | |
| ToppCell | normal-na-Lymphocytic_NK-T_mait-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.08e-03 | 180 | 17 | 2 | e66a8a61b3576ac37de7c559d16d4ed4f7a2fc78 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_LINC01474|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.08e-03 | 180 | 17 | 2 | 2ae39e26a8e7d5d4d3e1e71609a8ec36fd9855aa | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-03 | 180 | 17 | 2 | 8bf6e8b6b45ce42f8c5f23e7cd1752ec8b3fa2d2 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-03 | 180 | 17 | 2 | 0677bf4a5177d9cbc6716195bd966eeae8de2f31 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_NK-T_NK-ILC_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.08e-03 | 180 | 17 | 2 | a999a6d219a8e58a8b63802ddf8c95ffaab9cfa0 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.10e-03 | 181 | 17 | 2 | 6e8c5460021d3999daec58e3d6661a6fa998fd16 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-Pleural_Mac|normal_Lymph_Node / Location, Cell class and cell subclass | 2.10e-03 | 181 | 17 | 2 | 921e917f83105896ad8918dc134b871708024021 | |
| ToppCell | -Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 2.10e-03 | 181 | 17 | 2 | ef579e958f334da0f9415aa7e3d5c02c807954a6 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.10e-03 | 181 | 17 | 2 | 03a303cd2f366f09c18b118bbba6f5e3f95ad56c | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-CD1c+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 2.10e-03 | 181 | 17 | 2 | cc7ae1221a28bc404138a7efee0ad08a19cc3d86 | |
| ToppCell | facs-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l54|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.13e-03 | 182 | 17 | 2 | d22ab50b135482915687c70e6dad29bfe2bb2c68 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-7|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.13e-03 | 182 | 17 | 2 | af16334fec2c757b03c84cf252d00e92fa81e4cd | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.15e-03 | 183 | 17 | 2 | 6d98973098c6d20c5305bce6a83a549a7d8dbfba | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.15e-03 | 183 | 17 | 2 | b5d041d0a3506c33de72bf14fa0443f4410fddf1 | |
| ToppCell | IPF-Lymphoid-ILC_B|Lymphoid / Disease state, Lineage and Cell class | 2.15e-03 | 183 | 17 | 2 | 9b507547e6adf78e46e7f542cd9958224ec5826a | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Epithelial-large_intestine_goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-03 | 183 | 17 | 2 | ee9c88be88221b7ad4ea9f890b17d6156fb3432e | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.15e-03 | 183 | 17 | 2 | 803376f5260de83c48d4f7301278d078a32b3e6e | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.15e-03 | 183 | 17 | 2 | cc7f5a17b40e8d901885174922e5fa8877643071 | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Epithelial-Goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-03 | 183 | 17 | 2 | c52b84034503d931f7b87312d2ff86daff14152d | |
| ToppCell | (2)_5-FU-(4)_COL2.3+_osteoblasts|World / Stress and Cell class | 2.17e-03 | 184 | 17 | 2 | 684d05340a3dfb8aa08b881516a37f9627a10448 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-ILC3|lymph-node_spleen / Manually curated celltypes from each tissue | 2.17e-03 | 184 | 17 | 2 | 479e60f76c191253e23699c9dd7ef7efc08c59ad | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-03 | 185 | 17 | 2 | fd1911b57927c03470f9387962ca9581e5643fb3 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.20e-03 | 185 | 17 | 2 | 9d53e0a92e4f99370be2e4be1dd737630796b1ca | |
| ToppCell | facs-Large_Intestine-Distal-3m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-03 | 185 | 17 | 2 | 7a18d525de6f874924bfc61b9666b307da86421a | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.20e-03 | 185 | 17 | 2 | c85bba1210f1d389add3e40be9b96abac40cf8c1 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.20e-03 | 185 | 17 | 2 | 739260f8abebaf10a5cc49d91726278579e26170 | |
| ToppCell | Influenza-Influenza_Severe-Myeloid-Neutrophil|Influenza_Severe / Disease, condition lineage and cell class | 2.22e-03 | 186 | 17 | 2 | 1dfcec9196d4db76fba3abc74e85885b1fb98b87 | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-03 | 186 | 17 | 2 | 2f103ce2427f9cf2c1fafb6bd6045c5863a47549 | |
| ToppCell | facs-Lung-EPCAM-24m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-03 | 186 | 17 | 2 | 3c4994a1a7db06a61da8170e45e06aaef7896592 | |
| ToppCell | facs-Lung-EPCAM-24m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-03 | 186 | 17 | 2 | a583d6fc0f1e729f6e9fd18d7b49d6eab9ca32b9 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_T-T_NK-NK_T_cell|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.22e-03 | 186 | 17 | 2 | b099cb0902e9afb11218d70407d3cab212343c6d | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.24e-03 | 187 | 17 | 2 | fa0452f3382c22c0391b241d06504fda3c6a19f0 | |
| ToppCell | droplet-Spleen-nan-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-03 | 187 | 17 | 2 | c81d11d9fdc22dc39222f62c2888025c2e8c3e65 | |
| ToppCell | TCGA-Prostate-Primary_Tumor|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.24e-03 | 187 | 17 | 2 | 3e6a95c912dad5d61e10497ffaafd2b9027cd13a | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.24e-03 | 187 | 17 | 2 | 8c69fd469df2915c56ede534cee3ef23d5f64ebf | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-03 | 187 | 17 | 2 | b7689e7f6511920cd2beff27389555fddf685f61 | |
| Computational | Neighborhood of CDH11 | 1.08e-04 | 25 | 7 | 2 | GNF2_CDH11 | |
| Disease | cholesteryl esters to total lipids in medium LDL percentage | 1.82e-04 | 37 | 16 | 2 | EFO_0022252 | |
| Disease | cholesterol in medium LDL measurement | 3.19e-04 | 49 | 16 | 2 | EFO_0022224 | |
| Disease | phospholipids in medium LDL measurement | 3.19e-04 | 49 | 16 | 2 | EFO_0022183 | |
| Disease | total lipids in medium LDL | 3.60e-04 | 52 | 16 | 2 | EFO_0022180 | |
| Disease | free cholesterol to total lipids in large HDL percentage | 4.17e-04 | 56 | 16 | 2 | EFO_0022279 | |
| Disease | concentration of chylomicrons and extremely large VLDL particles measurement | 4.63e-04 | 59 | 16 | 2 | EFO_0022260 | |
| Disease | cholesterol in chylomicrons and extremely large VLDL measurement | 4.79e-04 | 60 | 16 | 2 | EFO_0021898 | |
| Disease | free cholesterol in VLDL measurement | 4.95e-04 | 61 | 16 | 2 | EFO_0022276 | |
| Disease | triglycerides to total lipids in very large HDL percentage | 5.11e-04 | 62 | 16 | 2 | EFO_0022339 | |
| Disease | free cholesterol in very large HDL measurement | 5.11e-04 | 62 | 16 | 2 | EFO_0022273 | |
| Disease | triglycerides in small HDL measurement | 5.11e-04 | 62 | 16 | 2 | EFO_0022158 | |
| Disease | free cholesterol in chylomicrons and extremely large VLDL measurement | 5.11e-04 | 62 | 16 | 2 | EFO_0022263 | |
| Disease | total lipids in chylomicrons and extremely large VLDL measurement | 5.11e-04 | 62 | 16 | 2 | EFO_0022306 | |
| Disease | free cholesterol to total lipids in medium LDL percentage | 5.28e-04 | 63 | 16 | 2 | EFO_0022283 | |
| Disease | phospholipids in chylomicrons and extremely large VLDL measurement | 5.28e-04 | 63 | 16 | 2 | EFO_0022292 | |
| Disease | triglycerides to total lipids in very small VLDL percentage | 6.33e-04 | 69 | 16 | 2 | EFO_0022341 | |
| Disease | cholesteryl esters to total lipids in very small VLDL percentage | 6.70e-04 | 71 | 16 | 2 | EFO_0022259 | |
| Disease | free cholesterol to total lipids in large LDL percentage | 7.28e-04 | 74 | 16 | 2 | EFO_0022280 | |
| Disease | monounsaturated fatty acids; 16:1, 18:1 measurement | 8.08e-04 | 78 | 16 | 2 | EFO_0022187 | |
| Disease | low density lipoprotein cholesterol measurement, lipid measurement | 1.71e-03 | 114 | 16 | 2 | EFO_0004529, EFO_0004611 | |
| Disease | total cholesterol measurement, low density lipoprotein cholesterol measurement | 1.71e-03 | 114 | 16 | 2 | EFO_0004574, EFO_0004611 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipid measurement | 1.90e-03 | 120 | 16 | 2 | EFO_0004611, EFO_0004639 | |
| Disease | cholesteryl ester measurement, low density lipoprotein cholesterol measurement | 2.09e-03 | 126 | 16 | 2 | EFO_0004611, EFO_0010351 | |
| Disease | free cholesterol measurement, low density lipoprotein cholesterol measurement | 2.46e-03 | 137 | 16 | 2 | EFO_0004611, EFO_0008591 | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 2.71e-03 | 144 | 16 | 2 | EFO_0004611, EFO_0020943 | |
| Disease | insomnia, total blood protein measurement | 2.86e-03 | 148 | 16 | 2 | EFO_0004536, EFO_0004698 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 3.06e-03 | 153 | 16 | 2 | EFO_0004611, EFO_0020946 | |
| Disease | C-reactive protein measurement | 3.41e-03 | 1206 | 16 | 4 | EFO_0004458 | |
| Disease | HMG CoA reductase inhibitor use measurement | 4.62e-03 | 189 | 16 | 2 | EFO_0009932 | |
| Disease | omega-6 polyunsaturated fatty acid measurement | 5.00e-03 | 197 | 16 | 2 | EFO_0005680 | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 5.15e-03 | 200 | 16 | 2 | EFO_0004611, EFO_0020945 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 6.31e-03 | 222 | 16 | 2 | EFO_0008317, EFO_0020943 | |
| Disease | total cholesterol measurement, very low density lipoprotein cholesterol measurement | 6.42e-03 | 224 | 16 | 2 | EFO_0004574, EFO_0008317 | |
| Disease | cholesteryl ester measurement, very low density lipoprotein cholesterol measurement | 6.47e-03 | 225 | 16 | 2 | EFO_0008317, EFO_0010351 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 6.47e-03 | 225 | 16 | 2 | EFO_0008317, EFO_0020947 | |
| Disease | phospholipids:total lipids ratio | 6.59e-03 | 227 | 16 | 2 | EFO_0020946 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PTSGPPRPLWLLLPL | 36 | Q9NY47 | |
| RPPAPLWPRLLLPLL | 11 | Q8IVU1 | |
| LSPPPAALPFLLLLW | 11 | Q9P244 | |
| FLPFLWALGTLPPPD | 251 | Q63HM2 | |
| WPPPGLGPFLLLLLL | 11 | Q04756 | |
| WRPPPPPLLLLLLWV | 6 | O95302 | |
| WGPPEPLLLYRAAPP | 1226 | O14559 | |
| PPLLLLLLWAPPPSR | 21 | P20908 | |
| RPLPPIPFPRFPWFR | 51 | Q8NFU4 | |
| PPLFSPRPLPRLWPL | 26 | Q8NAJ2 | |
| PRPLPRLWPLPGTPF | 31 | Q8NAJ2 | |
| WPPWPPLLFLLLLPG | 11 | Q6UY18 | |
| LPGILPLPKLFPRNW | 2171 | A2VEC9 | |
| WLPFPVLLLAALPPV | 6 | Q9Y3A6 | |
| SPPVLIPPLRILTPW | 1116 | Q6GYQ0 | |
| PLPLVPRPWFLPSLF | 16 | Q8WVZ1 | |
| PFPLSPILLSRPGWL | 81 | Q8N0V1 | |
| ALLPSRSPPTPLLWP | 6 | Q92692 |